Please assess the completion status of the following clinical trial:

Trial Title: Faecal Microbiota Transplantation in Ulcerative Colitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ulcerative colitis \>3 months duration~* Active mild-moderate ulcerative colitis (Mayo 4-10)~* Ulcerative colitis of any extent except isolated proctitis \< 5cm~* Live within driving distance of clinical site (to attend multiple study visits)~Exclusion Criteria:~* Pregnancy~* Active gastrointestinal infection~* Other gastrointestinal disease / comorbidities~* Prior colonic surgery~* Recent antibiotic or probiotic use~* Prednisone \> 20mg~* Monoclonal antibody immunosuppressive therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- FMT infusions (Type: ACTIVE_COMPARATOR): FMT infusions constituted from stool provided by healthy, screened donors
- Placebo arm (Type: PLACEBO_COMPARATOR): Placebo infusions

Based on this trial design, predict the completion outcome and termination type (if applicable).